We are pleased to announce that four (!) Harris Sliwoski attorneys have all been recognized as Global Top 200 Psychedelic Lawyers and Policy & Regulatory Experts for 2023 by the Cannabis Law Report. The Cannabis Law Report compiles a directory of lawyers that it considers to be the best legal minds, whether they come from
Register Here Harris Sliwoski attorneys, Paul Coble, Griffen Thorne, and Vincent Sliwoski, will be presenting on the “Legal and Regulatory Landscape for Psychedelics” in the following CLE webinar on January 12th, 2023, hosted by The Seminar Group. “This program will provide an overview of emerging drug therapies, including psilocybin, ketamine infusion clinics, MDMA and other
Oregon psilocybin licensing kicks off in just over a month. We are finally in the home stretch of the two-year run-up following the passage of Measure 109. At this point, many people are forming psilocybin businesses and raising money for these new ventures. What’s old is new again We went through similar business structuring and
There’s been a lot of news about Tuesday’s election. One of the things that hasn’t made the waves is Colorado’s approval of Prop. 122, which will pave the way for psilocybin clinics like in Oregon. Prop. 122 is actually much broader than Oregon’s Measure 109, and legalizes psychedelics far beyond just psilocybin. Many expressed opposition
Next month, Colorado voters will decide the fate of Proposition 122, named the Natural Medicine Health Act of 2022 (NMHA). If passed, NHMA would legalize a host of psychedelics in Colorado. Today, we’ll look at what NMHA would do. Natural Medicine Health Act of 2022 NMHA is modeled on – or at least influenced by
Our psychedelics team routinely fields questions from non-Oregon residents looking for Oregon psilocybin licenses. However, one of Measure 109‘s more infamous requirements is its residency requirement. These provisions require that, until January 1, 2025, manufacturing facilities and service centers must have majority ownership by individual(s) who have resided in Oregon for at least two years.
In March of this year, the Washington State Legislature passed Senate Bill 5693. Section 211, subpart 99 of this bill directs the Washington State Health Care Authority (HCA) to create a psilocybin work group to assess the feasibility of bills like Senate Bill 5660 (see our initial take on that one here). In particular, the
The Oregon Health Authority (OHA) released the rest of its draft psilocybin rules as predicted a few weeks back. We’ve had a minute to look at them. This post and the next few will cover some of the high points. In general, OHA did a good job implementing the Oregon Psilocybin Advisory Board’s (“Board”) recommendations
This will be one of the most important weeks for Oregon psilocybin to date, at least from a news and public information perspective. This is because we expect the Oregon Health Authority (OHA) to publish all remaining proposed administrative rules for the Oregon psilocybin program. The forthcoming rules should cover everything outlined in Measure 109
Welcome to the fifth installment in this series surveying business and regulatory issues in the Oregon psilocybin program. Today I will cover intellectual property considerations for Oregon psilocybin businesses. My law firm has written and presented many hundreds of times on intellectual property and controlled substances over the years. Mostly, this material focused on the
